Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 52

1.

Establishment and characterization of a novel vincristine-resistant diffuse large B-cell lymphoma cell line containing the 8q24 homogeneously staining region.

Mizuno S, Hanamura I, Ota A, Karnan S, Kanasugi J, Nakamura A, Takasugi S, Uchino K, Horio T, Goto M, Murakami S, Gotou M, Yamamoto H, Watarai M, Shikami M, Hosokawa Y, Miwa H, Taniwaki M, Ueda R, Nitta M, Takami A.

FEBS Open Bio. 2018 Nov 20;8(12):1977-1991. doi: 10.1002/2211-5463.12538. eCollection 2018 Dec.

2.

Establishment and characterization of CRISPR/Cas9-mediated NF2-/- human mesothelial cell line: Molecular insight into fibroblast growth factor receptor 2 in malignant pleural mesothelioma.

Wahiduzzaman M, Karnan S, Ota A, Hanamura I, Murakami H, Inoko A, Rahman ML, Hyodo T, Konishi H, Tsuzuki S, Hosokawa Y.

Cancer Sci. 2019 Jan;110(1):180-193. doi: 10.1111/cas.13871. Epub 2018 Dec 14.

3.

The plant alkaloid conophylline inhibits matrix formation of fibroblasts.

Tezuka T, Ota A, Karnan S, Matsuura K, Yokoo K, Hosokawa Y, Vigetti D, Passi A, Hatano S, Umezawa K, Watanabe H.

J Biol Chem. 2018 Dec 28;293(52):20214-20226. doi: 10.1074/jbc.RA118.005783. Epub 2018 Oct 30.

PMID:
30377255
4.

Generation of PTEN‑knockout (‑/‑) murine prostate cancer cells using the CRISPR/Cas9 system and comprehensive gene expression profiling.

Takao A, Yoshikawa K, Karnan S, Ota A, Uemura H, De Velasco MA, Kura Y, Suzuki S, Ueda R, Nishino T, Hosokawa Y.

Oncol Rep. 2018 Nov;40(5):2455-2466. doi: 10.3892/or.2018.6683. Epub 2018 Sep 5.

PMID:
30226608
5.

Novel combined Ato-C treatment synergistically suppresses proliferation of Bcr-Abl-positive leukemic cells in vitro and in vivo.

Wahiduzzaman M, Ota A, Karnan S, Hanamura I, Mizuno S, Kanasugi J, Rahman ML, Hyodo T, Konishi H, Tsuzuki S, Takami A, Hosokawa Y.

Cancer Lett. 2018 Oct 1;433:117-130. doi: 10.1016/j.canlet.2018.06.027. Epub 2018 Jun 23.

PMID:
29944906
6.

Inhibition of NADPH oxidase 2 induces apoptosis in osteosarcoma: The role of reactive oxygen species in cell proliferation.

Kitamoto K, Miura Y, Karnan S, Ota A, Konishi H, Hosokawa Y, Sato K.

Oncol Lett. 2018 May;15(5):7955-7962. doi: 10.3892/ol.2018.8291. Epub 2018 Mar 19.

7.

Novel ATP-competitive Akt inhibitor afuresertib suppresses the proliferation of malignant pleural mesothelioma cells.

Yamaji M, Ota A, Wahiduzzaman M, Karnan S, Hyodo T, Konishi H, Tsuzuki S, Hosokawa Y, Haniuda M.

Cancer Med. 2017 Nov;6(11):2646-2659. doi: 10.1002/cam4.1179. Epub 2017 Sep 27.

8.

Versican A-subdomain is required for its adequate function in dermal development.

Hatano S, Nagai N, Sugiura N, Tsuchimoto J, Isogai Z, Kimata K, Ota A, Karnan S, Hosokawa Y, Watanabe H.

Connect Tissue Res. 2018 Mar;59(2):178-190. doi: 10.1080/03008207.2017.1324432. Epub 2017 Jun 8.

PMID:
28488903
9.

Confounding features of ectopic craniopharyngioma: A differential for tumors showing diffusion restriction.

Karnan S, Krishnamoorthy V, Natarajan K, Sathyanathan BP.

Asian J Neurosurg. 2017 Jan-Mar;12(1):123-126. doi: 10.4103/1793-5482.149999.

10.

Δ40p53α suppresses tumor cell proliferation and induces cellular senescence in hepatocellular carcinoma cells.

Ota A, Nakao H, Sawada Y, Karnan S, Wahiduzzaman M, Inoue T, Kobayashi Y, Yamamoto T, Ishii N, Ohashi T, Nakade Y, Sato K, Itoh K, Konishi H, Hosokawa Y, Yoneda M.

J Cell Sci. 2017 Feb 1;130(3):614-625. doi: 10.1242/jcs.190736. Epub 2016 Dec 15.

11.

Inhibition of Nox1 induces apoptosis by attenuating the AKT signaling pathway in oral squamous cell carcinoma cell lines.

Ito K, Ota A, Ono T, Nakaoka T, Wahiduzzaman M, Karnan S, Konishi H, Furuhashi A, Hayashi T, Yamada Y, Hosokawa Y, Kazaoka Y.

Oncol Rep. 2016 Nov;36(5):2991-2998. doi: 10.3892/or.2016.5068. Epub 2016 Sep 5.

PMID:
27600098
12.

Improved methods of AAV-mediated gene targeting for human cell lines using ribosome-skipping 2A peptide.

Karnan S, Ota A, Konishi Y, Wahiduzzaman M, Hosokawa Y, Konishi H.

Nucleic Acids Res. 2016 Apr 7;44(6):e54. doi: 10.1093/nar/gkv1338. Epub 2015 Dec 10.

13.

Overexpression of salivary-type amylase reduces the sensitivity to bortezomib in multiple myeloma cells.

Mizuno S, Hanamura I, Ota A, Karnan S, Narita T, Ri M, Mizutani M, Goto M, Gotou M, Tsunekawa N, Shikami M, Iida S, Hosokawa Y, Miwa H, Ueda R, Nitta M, Takami A.

Int J Hematol. 2015 Nov;102(5):569-78. doi: 10.1007/s12185-015-1859-0. Epub 2015 Sep 4.

PMID:
26341959
14.

Inhibition of NADPH oxidase 4 induces apoptosis in malignant mesothelioma: Role of reactive oxygen species.

Tanaka M, Miura Y, Numanami H, Karnan S, Ota A, Konishi H, Hosokawa Y, Hanyuda M.

Oncol Rep. 2015 Oct;34(4):1726-32. doi: 10.3892/or.2015.4155. Epub 2015 Jul 27.

PMID:
26238284
15.

Plumbagin suppresses tumor cell growth in oral squamous cell carcinoma cell lines.

Ono T, Ota A, Ito K, Nakaoka T, Karnan S, Konishi H, Furuhashi A, Hayashi T, Yamada Y, Hosokawa Y, Kazaoka Y.

Oral Dis. 2015 May;21(4):501-11. doi: 10.1111/odi.12310. Epub 2015 Jan 29.

PMID:
25580997
16.

High-resolution 400K oligonucleotide array comparative genomic hybridization analysis of neurofibromatosis type 1-associated cutaneous neurofibromas.

Asai A, Karnan S, Ota A, Takahashi M, Damdindorj L, Konishi Y, Hossain E, Konishi H, Nagata A, Yokoo K, Hosokawa Y.

Gene. 2015 Mar 10;558(2):220-6. doi: 10.1016/j.gene.2014.12.064. Epub 2015 Jan 3.

PMID:
25562418
17.

Lipopolysaccharide augments the uptake of oxidized LDL by up-regulating lectin-like oxidized LDL receptor-1 in macrophages.

Hossain E, Ota A, Karnan S, Takahashi M, Mannan SB, Konishi H, Hosokawa Y.

Mol Cell Biochem. 2015 Feb;400(1-2):29-40. doi: 10.1007/s11010-014-2259-0. Epub 2014 Oct 28.

PMID:
25348362
18.

A comparative analysis of constitutive promoters located in adeno-associated viral vectors.

Damdindorj L, Karnan S, Ota A, Hossain E, Konishi Y, Hosokawa Y, Konishi H.

PLoS One. 2014 Aug 29;9(8):e106472. doi: 10.1371/journal.pone.0106472. eCollection 2014.

19.
20.

Clonal heterogeneity of lymphoid malignancies correlates with poor prognosis.

Suguro M, Yoshida N, Umino A, Kato H, Tagawa H, Nakagawa M, Fukuhara N, Karnan S, Takeuchi I, Hocking TD, Arita K, Karube K, Tsuzuki S, Nakamura S, Kinoshita T, Seto M.

Cancer Sci. 2014 Jul;105(7):897-904. doi: 10.1111/cas.12442. Epub 2014 Jul 1.

Supplemental Content

Loading ...
Support Center